Literature DB >> 22468019

Recent Development in Carbohydrate Based Anti-cancer Vaccines.

Zhaojun Yin1, Xuefei Huang.   

Abstract

The development of carbohydrate based anti-n>an class="Disease">cancer vaccines is of high current interests. Herein, the latest development in this exciting field is reviewed. After a general introduction about tumor associated carbohydrate antigens and immune responses, the review is focused on the various strategies that have been developed to enhance the immunogenecity of these antigens. The results from animal studies and clinical trials are presented.

Entities:  

Year:  2012        PMID: 22468019      PMCID: PMC3312792          DOI: 10.1080/07328303.2012.659364

Source DB:  PubMed          Journal:  J Carbohydr Chem        ISSN: 0732-8303            Impact factor:   1.667


  148 in total

1.  Synthesis of MUC1-lipopeptide chimeras.

Authors:  Brendan L Wilkinson; Lara R Malins; Candy K Y Chun; Richard J Payne
Journal:  Chem Commun (Camb)       Date:  2010-07-28       Impact factor: 6.222

2.  Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.

Authors:  Fan Yang; Xiu-Jing Zheng; Chang-Xin Huo; Yue Wang; Ye Zhang; Xin-Shan Ye
Journal:  ACS Chem Biol       Date:  2011-01-07       Impact factor: 5.100

3.  Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.

Authors:  Ravindra A De Silva; Qianli Wang; Tristan Chidley; Dananjaya K Appulage; Peter R Andreana
Journal:  J Am Chem Soc       Date:  2009-07-22       Impact factor: 15.419

4.  Synthesis of a dimeric Lewis antigen and the evaluation of the epitope specificity of antibodies elicited in mice.

Authors:  Therese Buskas; Yanhong Li; Geert-Jan Boons
Journal:  Chemistry       Date:  2005-09-05       Impact factor: 5.236

5.  A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain.

Authors:  D N Posnett; H McGrath; J P Tam
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

Review 6.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

7.  Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.

Authors:  G Ritter; E Ritter-Boosfeld; R Adluri; M Calves; S Ren; R K Yu; H F Oettgen; L J Old; P O Livingston
Journal:  Int J Cancer       Date:  1995-09-15       Impact factor: 7.396

8.  GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

Authors:  F Helling; A Shang; M Calves; S Zhang; S Ren; R K Yu; H F Oettgen; P O Livingston
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

Review 9.  Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

Authors:  S Hakomori
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

10.  New addresses on an addressable virus nanoblock; uniquely reactive Lys residues on cowpea mosaic virus.

Authors:  Anju Chatterji; Wendy F Ochoa; Melissa Paine; B R Ratna; John E Johnson; Tianwei Lin
Journal:  Chem Biol       Date:  2004-06
View more
  40 in total

1.  Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.

Authors:  Qian Qin; Zhaojun Yin; Philip Bentley; Xuefei Huang
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

2.  Immobilization of glycans on solid surfaces for application in glycomics.

Authors:  Crystal L O'Neil; Keith J Stine; Alexei V Demchenko
Journal:  J Carbohydr Chem       Date:  2018-04-27       Impact factor: 1.667

Review 3.  Recent advances in tumor associated carbohydrate antigen based chimeric antigen receptor T cells and bispecific antibodies for anti-cancer immunotherapy.

Authors:  Zahra Rashidijahanabad; Xuefei Huang
Journal:  Semin Immunol       Date:  2020-01-22       Impact factor: 11.130

4.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

5.  Tobacco mosaic virus as a new carrier for tumor associated carbohydrate antigens.

Authors:  Zhaojun Yin; Huong Giang Nguyen; Sudipa Chowdhury; Philip Bentley; Michael A Bruckman; Adeline Miermont; Jeffrey C Gildersleeve; Qian Wang; Xuefei Huang
Journal:  Bioconjug Chem       Date:  2012-08-02       Impact factor: 4.774

6.  Comparative immunological studies of tumor-associated Lewis X, Lewis Y, and KH-1 antigens.

Authors:  Jiatong Guo; Wenjie Jiang; Qingjiang Li; Mohit Jaiswal; Zhongwu Guo
Journal:  Carbohydr Res       Date:  2020-03-31       Impact factor: 2.104

7.  Quantifying the Efficiency of N-Phenyl-D-mannosamine to Metabolically Engineer Sialic Acid on Cancer Cell Surface.

Authors:  Zhifang Zhou; Guochao Liao; Sergejs Stepanovs; Zhongwu Guo
Journal:  J Carbohydr Chem       Date:  2014-11-01       Impact factor: 1.667

8.  Sequence Ion Structures and Dissociation Chemistry of Deprotonated Sucrose Anions.

Authors:  Benjamin J Bythell; Jordan M Rabus; Ashley R Wagoner; Maha T Abutokaikah; Philippe Maître
Journal:  J Am Soc Mass Spectrom       Date:  2018-10-03       Impact factor: 3.109

9.  6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Jun Liao; Luning Zu; Qiuye Wu; Zhongwu Guo
Journal:  ACS Infect Dis       Date:  2015-12-30       Impact factor: 5.084

10.  Chemoenzymatic synthesis of mono- and di-fluorinated Thomsen-Friedenreich (T) antigens and their sialylated derivatives.

Authors:  Jun Yan; Xi Chen; Fengshan Wang; Hongzhi Cao
Journal:  Org Biomol Chem       Date:  2012-12-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.